Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Good morning. We’ve got a lot of new data to dig into, so let’s get straight to it.
Medicare delays pilot for covering obesity drugs
One of the key health care accomplishments the Trump administration wanted to claim was securing coverage of obesity drugs for seniors. That plan is now unraveling.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
